Parking Bulb Blue Ice LED 27 T10 Canbus Light J Acura For W1 2825 194 168 W5W Car & Truck LED Light Bulbs


  1. Home
  2. Parking Bulb Blue Ice LED 27 T10 Canbus Light J Acura For W1 2825 194 168 W5W
  1. facebook
  2. twitter
  3. linkedin
  4. pinterest
Canbus T10 27 LED Ice Blue Bulb Parking Light W5W 168 194 2825 W1 For Acura J
Condition: New To Fit: Parking Light
Placement on Vehicle: Parking Light Interchange Part Number: T10, 168, 192, 193, 194, 2825, 916, 2821, 2827, 12961, 12256, 12396
Brand:

WP51

Bulb Color: Ice Blue
Fitment Type: Direct Replacement EAN:

Does not apply

Number of Bulbs: 2 UPC:

Does not apply

Warranty: 1 Year Ballast Included: No
Voltage: 12V Manufacturer Part Number:

W27CBT10BIB

published on tue nov 09 2021

Parking Bulb Blue Ice LED 27 T10 Canbus Light J Acura For W1 2825 194 168 W5W Car & Truck LED Light Bulbs

gandhi, s., klein, j., robertson, a., pena-hernandez, m. a.,

Parking Bulb Blue Ice LED 27 T10 Canbus Light J Acura For W1 2825 194 168 W5W Car & Truck LED Light Bulbs

lin, m. j., roychoudhury, p., lu, p., fournier, j., ferguson, d., mohamed bakhash, s. a., muenker, m. c., srivathsan, a., wunder, e. a., kerantzas, n., wang, w., pyle, a., wilen, c. b., ogbuagu, o., greninger ,, a. l., iwasaki, a., schulz, w. l., ko, a. i.

sars-cov-2 remdesivir resistance mutations have been generated in vitro but have not been reported in patients receiving treatment with the antiviral agent. we present a case of an immunocompromised patient with acquired b-cell deficiency who developed an indolent, protracted course of sars-cov-2 infection. remdesivir therapy alleviated symptoms and produced a transient virologic response, but her course was complicated by recrudescence of high-grade viral shedding. whole genome sequencing identified a mutation, e802d, in the nsp12 rna-dependent rna polymerase which was not present in pre-treatment specimens. in vitro experiments demonstrated that the mutation conferred a ~6-fold increase in remdesivir ic50 but resulted in a fitness cost in the absence of remdesivir. sustained clinical and virologic response was achieved after treatment with casirivimab-imdevimab. although the fitness cost observed in vitro may limit the risk posed by e802d,

, this case illustrates the importance of monitoring for remdesivir resistance and the potential benefit of combinatorial therapies in immunocompromised patients with sars-cov-2 infection.

509
1.2k
EVGENIA.RU RSS